Diagnostic Accuracy of Aerodigestive Ultrasound for Predicting Swallowing Disorders
Launched by HOPITAL FORCILLES · Mar 15, 2021
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Swallowing disorders management requires an accurate recognition of implicated anatomical structures and pathways. The usual clinical assessment of swallowing disorders lack of reliability and accuracy. The gold standard remains the videofluoroscopy. However, this imaging technique lacks reliability and standardisation. Moreover, videofluoroscopy not easily available is time and material consuming and implies ionisation. Ultrasound imaging, which can be performed at the patient's bedside, is a non-invasive tool. It allows the evaluation of the main structures involved in all the swallowing ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Outpatients refered to swallowing assessment at the Forcilles' hospital;
- • Medical indication to perform a videofluoroscopy;
- • Ultrasonographer available;
- • Age \> 18 years old;
- • Membership of a social insurance sheme;
- • Patient provides consent.
- Exclusion Criteria:
- • Previous laryngectomy surgery;
- • Refusal to participate in the study;
- • Known pregnancy;
- • Person subject to judicial health protection;
- • Cognitive disorder incompatible with the understanding of instructions;
- • Patient under guardianship or curatorship.
About Hopital Forcilles
Hopital Forcilles is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on patient safety and ethical standards, the hospital collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous studies across various therapeutic areas. By integrating cutting-edge technologies and methodologies, Hopital Forcilles aims to contribute significantly to the development of new treatments and therapies, ultimately enhancing health outcomes for communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Férolles Attilly, Ile De France, France
Patients applied
Trial Officials
Carlos Diaz Lopez, PT
Principal Investigator
Hôpital Forcilles-Fondation Cognacq-Jay
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials